Microbiology and Immunology, Virginia Commonwealth University, Richmond, VA 23298-0678, USA.
Hepatology. 2012 Jan;55(1):267-76. doi: 10.1002/hep.24681. Epub 2011 Nov 30.
Bile acids have been shown to be important regulatory molecules for cells in the liver and gastrointestinal tract. They can activate various cell signaling pathways including extracellular regulated kinase (ERK)1/2 and protein kinase B (AKT) as well as the G-protein-coupled receptor (GPCR) membrane-type bile acid receptor (TGR5/M-BAR). Activation of the ERK1/2 and AKT signaling pathways by conjugated bile acids has been reported to be sensitive to pertussis toxin (PTX) and dominant-negative Gα(i) in primary rodent hepatocytes. However, the GPCRs responsible for activation of these pathways have not been identified. Screening GPCRs in the lipid-activated phylogenetic family (expressed in HEK293 cells) identified sphingosine-1-phosphate receptor 2 (S1P(2) ) as being activated by taurocholate (TCA). TCA, taurodeoxycholic acid (TDCA), tauroursodeoxycholic acid (TUDCA), glycocholic acid (GCA), glycodeoxycholic acid (GDCA), and S1P-induced activation of ERK1/2 and AKT were significantly inhibited by JTE-013, a S1P(2) antagonist, in primary rat hepatocytes. JTE-013 significantly inhibited hepatic ERK1/2 and AKT activation as well as short heterodimeric partner (SHP) mRNA induction by TCA in the chronic bile fistula rat. Knockdown of the expression of S1P(2) by a recombinant lentivirus encoding S1P(2) shRNA markedly inhibited the activation of ERK1/2 and AKT by TCA and S1P in rat primary hepatocytes. Primary hepatocytes prepared from S1P(2) knock out (S1P(2) (-/-) ) mice were significantly blunted in the activation of the ERK1/2 and AKT pathways by TCA. Structural modeling of the S1P receptors indicated that only S1P(2) can accommodate TCA binding. In summary, all these data support the hypothesis that conjugated bile acids activate the ERK1/2 and AKT signaling pathways primarily through S1P(2) in primary rodent hepatocytes.
胆汁酸已被证明是肝脏和胃肠道细胞中重要的调节分子。它们可以激活各种细胞信号通路,包括细胞外调节激酶(ERK1/2)和蛋白激酶 B(AKT)以及 G 蛋白偶联受体(GPCR)膜型胆汁酸受体(TGR5/M-BAR)。已报道共轭胆汁酸激活 ERK1/2 和 AKT 信号通路对原代啮齿动物肝细胞中的百日咳毒素(PTX)和显性失活 Gα(i)敏感。然而,负责激活这些途径的 GPCR 尚未确定。在脂质激活的进化家族中筛选 GPCR(在 HEK293 细胞中表达),发现鞘氨醇-1-磷酸受体 2(S1P(2))可被牛磺胆酸钠(TCA)激活。牛磺胆酸钠(TCA)、牛脱氧胆酸钠(TDCA)、牛磺熊脱氧胆酸钠(TUDCA)、甘氨胆酸钠(GCA)、甘氨脱氧胆酸钠(GDCA)和 S1P 诱导的 ERK1/2 和 AKT 激活均被 S1P(2)拮抗剂 JTE-013 在原代大鼠肝细胞中显著抑制。JTE-013 显著抑制慢性胆瘘大鼠中 TCA 引起的肝 ERK1/2 和 AKT 激活以及短异二聚体伴侣(SHP)mRNA 的诱导。用编码 S1P(2) shRNA 的重组慢病毒转染下调 S1P(2)的表达,显著抑制 TCA 和 S1P 在大鼠原代肝细胞中对 ERK1/2 和 AKT 的激活。从 S1P(2)敲除(S1P(2) (-/-))小鼠制备的原代肝细胞中,TCA 激活 ERK1/2 和 AKT 途径的能力明显减弱。S1P 受体的结构建模表明,只有 S1P(2)可以容纳 TCA 结合。总之,所有这些数据支持这样的假设,即共轭胆汁酸主要通过原代啮齿动物肝细胞中的 S1P(2)激活 ERK1/2 和 AKT 信号通路。